Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,181 | 155 | 99.5% |
| Education | $12.02 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $329.34 | 19 | $0 (2021) |
| PFIZER INC. | $234.91 | 24 | $0 (2021) |
| Lilly USA, LLC | $221.88 | 16 | $0 (2021) |
| GlaxoSmithKline, LLC. | $220.08 | 14 | $0 (2021) |
| Novo Nordisk Inc | $154.26 | 10 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $153.00 | 11 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $132.11 | 11 | $0 (2021) |
| Allergan, Inc. | $119.84 | 9 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $108.74 | 9 | $0 (2020) |
| Astellas Pharma US Inc | $85.27 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $15.03 | 1 | ABBVIE INC. ($15.03) |
| 2021 | $506.96 | 30 | Novartis Pharmaceuticals Corporation ($80.45) |
| 2020 | $596.96 | 41 | GlaxoSmithKline, LLC. ($131.16) |
| 2019 | $277.39 | 28 | PFIZER INC. ($111.24) |
| 2018 | $399.51 | 27 | Novartis Pharmaceuticals Corporation ($106.76) |
| 2017 | $396.97 | 29 | Lilly USA, LLC ($70.02) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/02/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Gastroenterology | ||||||
| 09/22/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/20/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: PRIMARY CARE | ||||||
| 08/24/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Diabetes | ||||||
| 08/10/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/27/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.84 | General |
| 07/19/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: PRIMARY CARE | ||||||
| 07/13/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 06/24/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/15/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $12.23 | General |
| Category: Cardiovascular | ||||||
| 05/19/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiovascular | ||||||
| 05/13/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Respiratory | ||||||
| 05/11/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Diabetes | ||||||
| 05/06/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: RESPIRATORY | ||||||
| 05/04/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS, REYVOW | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: WOMENS HEALTH | ||||||
| 05/03/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Cardiovascular | ||||||
| 04/20/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: RESPIRATORY | ||||||
| 04/19/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2021 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/11/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Cardiovascular | ||||||
| 03/10/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: WOMENS HEALTH | ||||||
| 03/05/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 382 | 1,050 | $282,469 | $80,518 |
| 2022 | 8 | 256 | 755 | $221,578 | $60,749 |
| 2021 | 18 | 1,307 | 2,449 | $274,109 | $99,475 |
| 2020 | 27 | 1,756 | 3,077 | $318,966 | $108,966 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11043 | Removal of muscle and/or tissue, 20.0 sq cm or less | Office | 2023 | 32 | 122 | $70,991 | $20,493 | 28.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 84 | 350 | $61,932 | $19,192 | 31.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 54 | 193 | $48,910 | $15,270 | 31.2% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 25 | 50 | $17,020 | $4,089 | 24.0% |
| 17250 | Application of chemical to stop tissue regrowth in wound | Office | 2023 | 15 | 66 | $15,567 | $3,980 | 25.6% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 38 | 38 | $11,910 | $3,792 | 31.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 27 | 68 | $12,036 | $3,768 | 31.3% |
| 11043 | Removal of muscle and/or tissue, 20.0 sq cm or less | Facility | 2023 | 15 | 32 | $18,607 | $3,610 | 19.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 18 | 26 | $6,593 | $2,068 | 31.4% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 49 | 67 | $6,342 | $1,947 | 30.7% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 14 | 14 | $4,388 | $1,397 | 31.8% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2023 | 11 | 24 | $8,173 | $911.26 | 11.1% |
| 11043 | Removal of muscle and/or tissue, 20.0 sq cm or less | Office | 2022 | 23 | 121 | $72,709 | $20,853 | 28.7% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 49 | 197 | $42,367 | $13,237 | 31.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 49 | 154 | $25,373 | $7,859 | 31.0% |
| 11043 | Removal of muscle and/or tissue, 20.0 sq cm or less | Facility | 2022 | 11 | 45 | $27,041 | $5,197 | 19.2% |
| 17250 | Application of chemical to stop tissue regrowth in wound | Office | 2022 | 16 | 68 | $16,304 | $4,350 | 26.7% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 17 | 39 | $13,247 | $2,848 | 21.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 33 | 55 | $11,416 | $2,420 | 21.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 22 | 40 | $6,577 | $1,986 | 30.2% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 11 | 11 | $3,352 | $1,052 | 31.4% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Office | 2022 | 14 | 14 | $2,962 | $913.92 | 30.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 11 | 11 | $231.00 | $33.00 | 14.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 144 | 399 | $82,593 | $34,010 | 41.2% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 35 | 294 | $57,171 | $18,179 | 31.8% |
About Dr. Nathan Moore, MD
Dr. Nathan Moore, MD is a Family Medicine healthcare provider based in Paris, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093829822.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathan Moore, MD has received a total of $2,193 in payments from pharmaceutical and medical device companies, with $15.03 received in 2022. These payments were reported across 156 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,181).
As a Medicare-enrolled provider, Moore has provided services to 3,701 Medicare beneficiaries, totaling 7,331 services with total Medicare billing of $349,707. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Paris, KY
- Active Since 08/18/2006
- Last Updated 04/27/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1093829822
Products in Payments
- ENTRESTO (Drug) $284.82
- TRULICITY (Drug) $194.63
- TRELEGY ELLIPTA (Drug) $135.73
- UBRELVY (Drug) $91.60
- Ozempic (Drug) $87.59
- FARXIGA (Drug) $85.00
- CHANTIX (Drug) $79.08
- Vascepa (Drug) $74.11
- SOLIQUA 100/33 (Biological) $57.55
- VESICARE (Drug) $45.18
- EUCRISA (Drug) $45.01
- AIMOVIG (Biological) $44.52
- PREMARIN (Drug) $44.09
- ANORO ELLIPTA (Drug) $43.81
- PREVNAR - 13 (Biological) $42.44
- MYRBETRIQ (Drug) $40.09
- TOUJEO (Drug) $39.93
- VRAYLAR (Drug) $39.26
- JANUVIA (Drug) $38.35
- Trulance (Drug) $34.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Paris
Dr. Deepak Muthappa, M.d, M.D
Family Medicine — Payments: $63,711
Chad Trammell, Md, MD
Family Medicine — Payments: $12,953
Dr. Myers Hurt, Md, MD
Family Medicine — Payments: $9,776
Dr. Rahat Sheikh, Md, MD
Family Medicine — Payments: $5,248
Ernest White, Md, MD
Family Medicine — Payments: $4,298
Jeffrey Green, Md, MD
Family Medicine — Payments: $4,162